Discordances between Immunofixation (IFx) and Minimal Residual Disease (MRD) Assessment with Next-Generation Flow (NGF) and Sequencing (NGS) in Patients (Pts) with Multiple Myeloma (MM): Clinical and Pathogenic Significance

被引：0
|
作者：
Rodriguez, Sara
Goicoechea, Ibai
Gemenetzi, Katerina
Botta, Cirino
Agathangelidis, Andreas
Puig, Noemi
Cedena, Maria Teresa
Medina, Alejandro
Valdes-Mas, Rafael
Garces, Juan Jose
Perez, Jose J.
Burgos, Leire
Calasanz, Maria Jose
Alignani, Diego
Vilas-Zornoza, Amaia
Sarai, Sarvide
Prosper, Felipe
Martinez-Climent, Jose Angel
Orfao, Alberto
Garcia-Sanz, Ramon
Ubieto, Ana Jimenez
Lopez, Joaquin Martinez
Lahuerta, Juan Jose
Rosinol, Laura
Blade, Joan
Mateos, Maria-Victoria
Chatzidimitriou, Anastasia
San-Miguel, Jesus F.
Paiva, Bruno
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Role of clonoSEQ®, a Next-Generation Sequencing (NGS) Assay and PET/CT As a Measure of Minimal Residual Disease Negativity Among Patients with Multiple Myeloma
    Nooka, Ajay
    Bradley, Kyle
    Joseph, Nisha
    Hofmeister, Craig C.
    Dhodapkar, Madhav V.
    Boise, Larry H.
    Lonial, Sagar
    Li, Shiyong
    Kaufman, Jonathan L.
    BLOOD, 2020, 136
  • [22] MINIMAL RESIDUAL DISEASE (MRD) BY MULTIPARAMETER FLOW CYTOMETRY (MFC) AND NEXT-GENERATION SEQUENCING (NGS) IN NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA (NDMM): RESULTS FROM THE FORTE TRIAL
    Oliva, S.
    Genuardi, E.
    Rota-Scalabrini, D.
    Zamagni, E.
    Auclair, D.
    Jacob, A. P.
    Zambello, R.
    Spadano, A.
    Giuliani, N.
    Cuoghi, A.
    De Rosa, L.
    Visca, L.
    Gozzetti, A.
    Pietrantuono, G.
    Patriarca, F.
    de Fabritiis, P.
    Aquino, S.
    Kirsch, I. R.
    Offidani, M.
    Belotti, A.
    Musto, P.
    Boccadoro, M.
    Gay, F.
    HAEMATOLOGICA, 2021, 106 (10) : 74 - 74
  • [23] A comparison between next-generation sequencing and ASO-qPCR for minimal residual disease detection in multiple myeloma
    Takamatsu, Hiroyuki
    Murata, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Terasaki, Yasushi
    Yoshida, Takashi
    Faham, Malek
    Nakao, Shinji
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] A COMPARISON BETWEEN NEXT-GENERATION SEQUENCING AND ASO-QPCR FOR MINIMAL RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA
    Takamatsu, H.
    Murata, R.
    Zheng, J.
    Moorhead, M.
    Terasaki, Y.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    HAEMATOLOGICA, 2013, 98 : 101 - 102
  • [25] Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma
    Medina, Alejandro
    Jimenez, Cristina
    Puig, Noemi
    Sarasquete, Maria Eugenia
    Flores-Montero, Juan
    Garcia-Alvarez, Maria
    Prieto-Conde, Isabel
    Chillon, Carmen
    Alcoceba, Miguel
    Gonzalez-Calle, Veronica
    Gutierrez, Norma C.
    Jacobsen, Austin
    Vigil, Edgar
    Hutt, Kasey
    Huang, Ying
    Orfao, Alberto
    Gonzalez, Marcos
    Miller, Jeffrey
    Garcia-Sanz, Ramon
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (07) : 862 - 871
  • [26] Eight-color multiparameter flow cytometry (EuroFlow-NGF) is as sensitive as next-generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma
    Urushihara, Ryota
    Takezako, Naoki
    Yoroidaka, Takeshi
    Yamashita, Takeshi
    Murata, Ryoichi
    Satou, Kenji
    Nakao, Shinji
    Takamatsu, Hiroyuki
    EJHAEM, 2023, 4 (01): : 184 - 191
  • [27] Clinical validation of next-generation sequencing-based clonality assays for minimal residual disease tracking in multiple myeloma
    Lin, Chuanming
    Jian, Qijie
    Huang, Zoufang
    Xie, Shuiling
    Xin, Liuyan
    Wu, Haiyan
    Pang, Fei
    Liao, Changfeng
    Chen, Yijian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Comparison of Minimal Residual Disease Detection in Autografts of Patients with Multiple Myeloma between 8-Color Multiparameter Flow Cytometry (EuroFlow) and Next-Generation Sequencing
    Takamatsu, Hiroyuki
    Takezako, Naoki
    Wee, Rachel K.
    Yoroidaka, Takeshi
    Yamashita, Takeshi
    Murata, Ryoichi
    Matsue, Kosei
    Nakao, Shinji
    BLOOD, 2018, 132
  • [29] A Comparison Between Next-Generation Sequencing and ASO-qPCR For Minimal Residual Disease Detection In Multiple Myeloma: The Clinical Value In ASCT Setting
    Takamatsu, Hiroyuki
    Mura, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Yasushi, Terasaki
    Takashi, Yoshida
    Faham, Malek
    Nakao, Shinji
    BLOOD, 2013, 122 (21)
  • [30] A COMPARISON BETWEEN NEXT-GENERATION SEQUENCING AND ASO-QPCR FOR MINIMAL RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA: THE CLINICAL VALUE IN ASCT SETTING
    Takamatsu, H.
    Murata, R.
    Ito, S.
    Zheng, J.
    Moorhead, M.
    Terasaki, Y.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    HAEMATOLOGICA, 2014, 99 : 113 - 114
12345